David A. Siegel Aura Biosciences, Inc. Call Options Transaction History
Two Sigma Advisers, LP
- $43.8 Billion
- Q2 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding AURA
# of Institutions
81Shares Held
40.8MCall Options Held
50.8KPut Options Held
1.8K-
Matrix Capital Management Company, LP Waltham, MA6.92MShares$71.5 Million0.4% of portfolio
-
Eventide Asset Management, LLC Boston, MA5.8MShares$59.9 Million0.77% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA4.89MShares$50.5 Million0.07% of portfolio
-
Medicxi Ventures Management (Jersey) LTD3.04MShares$31.4 Million5.63% of portfolio
-
Black Rock Inc. New York, NY3.01MShares$31 Million0.0% of portfolio
About Aura Biosciences, Inc.
- Ticker AURA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 29,273,600
- Market Cap $302M
- Description
- Aura Biosciences, Inc. operates as a biotechnology company that develops therapies to treat cancer. The company develops virus-like drug conjugates (VDC) technology platform for the treat tumors of high unmet need in ocular and urologic oncology. It develops AU-011, a VDC candidate for the treatment of primary choroidal melanoma. It also develop...